Literature DB >> 1963084

Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.

T P Cripe1, A Alderborn, R D Anderson, S Parkkinen, P Bergman, T H Haugen, U Pettersson, L P Turek.   

Abstract

The P97 promoter upstream of the oncogenic early genes of human papillomavirus (HPV)-16 is active in keratinocytes and in cervical carcinoma cells due to a 5' keratinocyte-dependent cis enhancer. In this study, we have mapped the main enhancer activity to an 88-nucleotide (nt) fragment composed of multiple cis elements. A 63-nt promoter-proximal enhancer core was sufficient for P97 activation in a human keratinocytic cell line, HaCaT, and in cervical carcinoma cells. Although the enhancer functioned poorly in hepatoma cells or in fibroblasts, nuclear extracts from different cells protected similar cis elements from DNase I digestion. Two protected half-palindromic NF-I/CTF sites within the 63-nt core were necessary for its function; one represents a "cytokeratin element" (CK), a previously described 8-nt sequence shared with cytokeratin gene promoters. Both sites formed complexes of the same apparent size and relative binding affinity with NF-I/CTF-like factor(s) present in all cells tested. Although cell-dependent P97 activation could be determined by similar, yet distinct NF-I/CTF-like proteins, adjacent cis elements in the enhancer core were also required for function, and may thus interact with additional transcription factors. A 25-nt distal module with two AP-1 sites increased enhancer activity and cooperated with cis elements of the proximal core. Each AP-1 site as well as a third AP-1 site near the promoter bound c-Jun and Jun/Fos in vitro, and was activated by c-Jun and c-Fos in transfections. In addition to cell type-dependent activation, HPV-16 P97 transcription may therefore respond to growth factors and oncogene products via the AP-1 pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963084

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  42 in total

1.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes.

Authors:  F Thierry; G Spyrou; M Yaniv; P Howley
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.

Authors:  S Y Hou; S Y Wu; T Zhou; M C Thomas; C M Chiang
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Induction of the HPV16 enhancer activity by Jun-B and c-Fos through cooperation of the promoter-proximal AP-1 site and the epithelial cell type--specific regulatory element in fibroblasts.

Authors:  K Kikuchi; A Taniguchi; S Yasumoto
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.

Authors:  H D Royer; M P Freyaldenhoven; I Napierski; D D Spitkovsky; T Bauknecht; N Dathan
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

6.  Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.

Authors:  W Zhao; L T Chow; T R Broker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 7.  Transcription factor regulation of epidermal keratinocyte gene expression.

Authors:  R L Eckert; J F Welter
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

8.  Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.

Authors:  Vignesh Gunasekharan; Guylaine Haché; Laimonis Laimins
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

9.  Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.

Authors:  S Yasumoto; A Taniguchi; K Sohma
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  NFI is an essential positive transcription factor for human papillomavirus type 16 early gene expression.

Authors:  Amy Baldwin; Melissa K Hypes; Lucia Pirisi; Kim E Creek
Journal:  Open Virol J       Date:  2007-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.